Press Releases RxSight, Inc.

Equities

RXST

US78349D1072

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
58.47 ^USD	-1.76%		-4.38%	+45.01%

May. 21	Rxsight Insider Bought Shares Worth $305,457, According to a Recent SEC Filing	MT
May. 15	Transcript : RxSight, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	May. 13	GL
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	May. 13	AQ
RxSight, Inc. Announces Pricing of Public Offering of Common Stock	May. 08	GL
RxSight, Inc. Announces Proposed Public Offering of Common Stock	May. 08	GL
RxSight, Inc. Announces Proposed Public Offering of Common Stock	May. 08	AQ
RxSight, Inc. Reports First Quarter 2024 Financial Results	May. 06	GL
RxSight, Inc. Reports First Quarter 2024 Financial Results	May. 06	AQ
RxSight, Inc. to Present at the Bank of America Healthcare Conference	May. 01	GL
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024	Apr. 22	GL
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	Apr. 04	GL
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Mar. 27	GL
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference	Feb. 29	GL
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference	Feb. 29	AQ
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 28	GL
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 28	AQ
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	Feb. 14	GL
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	Feb. 14	AQ
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance	Jan. 07	AQ
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance	Jan. 07	GL
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference	Dec. 27	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases RxSight, Inc.

Equities

RXST

US78349D1072

Press Releases

Filters